Q32 Bio Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2017 | $6.5M | $4.5M | $2.0M | $277.0K |
| FY2018 | $-42.6M | $-67.5M | $24.9M | $2.6M |
| FY2019 | $-91.4M | $-113.2M | $21.8M | $7.6M |
| FY2020 | $-94.3M | $-98.1M | $3.7M | $13.2M |
| FY2021 | $-109.8M | $-112.1M | $2.4M | $17.2M |
| FY2022 | $-113.7M | $-114.9M | $1.3M | $13.1M |
| FY2023 | $-18.7M | $-18.7M | $5.0K | $1.4M |
| FY2024 | $-67.7M | $-67.8M | $75.0K | $4.4M |
| FY2025 | $-33.5M | $-33.5M | $0 | $5.3M |